The impact of previous disease-modifying treatment for HSCT outcome and the risk of new disease activity in MS S. Kvistad,J. Burman, L. Bo, A. K. Lehmann, G. K. Melve, A. Tolf, C. Zhukovsky,O. TorkildsenMULTIPLE SCLEROSIS JOURNAL(2021)引用 1|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要